Dear Doctor - Participate in the Survey on psoriatic arthritis " A new survey has found that psoriatic arthritis can have a significant impact on patients' quality of life. The study, which was conducted by the National Psoriasis Foundation (NPF), surveyed more than 3,500 people with psoriatic arthritis and found that the condition can severely affect patients physically, emotionally, and socially.The NPF survey found that psoriatic arthritis can cause pain, fatigue, stiffness, joint damage, and disability. The condition can also lead to depression and anxiety. In addition, the survey found that people with psoriatic arthritis are often socially isolated and have difficulty keeping up with work and daily activities."This survey provides new insights into the real-world impact of psoriatic arthritis," said NPF President Andrew Prince. "It's important for people with psoriatic arthritis to know they are not alone. There are a wide variety of resources available to help manage this complex disease." Participate in Surveys "
1.
Video: Liver transplant for patients with advanced colorectal cancer
2.
La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.
3.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
4.
AI is useful in low-resource areas for triaging breast masses.
5.
Does pollution cause cancer?
1.
Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review
2.
Bridging the Gap Between Cancer Treatment-Induced Cardiotoxicity and Regenerative Medicine
3.
Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense
4.
Unlocking the Potential of Onivyde: A New Hope for Cancer Treatment
5.
Beyond the Cure: The Emerging Role of Tissue-Agnostic Therapies in Palliative Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation